US1252691001 - Common Stock

Overall **CF** gets a fundamental rating of **7** out of 10. We evaluated **CF** against 84 industry peers in the **Chemicals** industry. **CF** has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. **CF** is cheap, but on the other hand it scores bad on growth. These ratings would make **CF** suitable for value investing!

In the past 5 years **CF** has always been profitable.

Each year in the past 5 years **CF** had a positive operating cash flow.

The **Return On Invested Capital** of **CF** (**10.68%**) is better than **90.48%** of its industry peers.

Measured over the past 3 years, the **Average Return On Invested Capital** for **CF** is significantly above the industry average of **6.70%**.

The last **Return On Invested Capital** (**10.68%**) for **CF** is well below the 3 year average (**21.67%**), which needs to be investigated, but indicates that **CF** had better years and this may not be a problem.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.36% | ||

ROE | 21.31% | ||

ROIC | 10.68% |

ROA(3y)14.38%

ROA(5y)9.97%

ROE(3y)40.51%

ROE(5y)29.88%

ROIC(3y)21.67%

ROIC(5y)15.19%

Looking at the **Profit Margin**, with a value of **19.03%**, **CF** belongs to the top of the industry, outperforming **95.24%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **CF** has grown nicely.

In the last couple of years the **Operating Margin** of **CF** has grown nicely.

In the last couple of years the **Gross Margin** of **CF** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 29.05% | ||

PM (TTM) | 19.03% | ||

GM | 34.34% |

OM growth 3Y30.93%

OM growth 5Y15.81%

PM growth 3Y44.1%

PM growth 5Y28.56%

GM growth 3Y24.16%

GM growth 5Y13.14%

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so **CF** is creating value.

An Altman-Z score of **2.50** indicates that **CF** is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Debt to FCF ratio of **CF** is **1.72**, which is an excellent value as it means it would take **CF**, only **1.72** years of fcf income to pay off all of its debts.

With an excellent **Debt to FCF ratio** value of **1.72**, **CF** belongs to the best of the industry, outperforming **90.48%** of the companies in the same industry.

A Debt/Equity ratio of **0.55** indicates that **CF** is somewhat dependend on debt financing.

Although **CF** does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.55 | ||

Debt/FCF | 1.72 | ||

Altman-Z | 2.5 |

ROIC/WACC1.3

WACC8.2%

The **Current ratio** of **CF** (**3.94**) is better than **86.90%** of its industry peers.

With an excellent **Quick ratio** value of **3.55**, **CF** belongs to the best of the industry, outperforming **90.48%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.94 | ||

Quick Ratio | 3.55 |

The earnings per share for **CF** have decreased strongly by **-59.53%** in the last year.

Measured over the past years, **CF** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **47.09%** on average per year.

EPS 1Y (TTM)-59.53%

EPS 3Y76.69%

EPS 5Y47.09%

EPS Q2Q%-68.97%

Revenue 1Y (TTM)-41.06%

Revenue growth 3Y17.15%

Revenue growth 5Y8.41%

Sales Q2Q%-26.94%

The **Earnings Per Share** is expected to grow by **0.45%** on average over the next years.

Based on estimates for the next years, **CF** will show a decrease in **Revenue**. The Revenue will decrease by **-0.40%** on average per year.

EPS Next Y-33.16%

EPS Next 2Y-14.54%

EPS Next 3Y-10%

EPS Next 5Y0.45%

Revenue Next Year-10.09%

Revenue Next 2Y-4.34%

Revenue Next 3Y-2.74%

Revenue Next 5Y-0.4%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The **Price/Earnings** ratio is **11.89**, which indicates a very decent valuation of **CF**.

When comparing the **Price/Earnings** ratio of **CF** to the average of the S&P500 Index (**28.24**), we can say **CF** is valued rather cheaply.

Based on the **Price/Forward Earnings** ratio, **CF** is valued a bit cheaper than 67.86% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.89 | ||

Fwd PE | 12.37 |

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **CF** indicates a rather cheap valuation: **CF** is cheaper than 88.10% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 7.97 | ||

EV/EBITDA | 5.56 |

The excellent profitability rating of **CF** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.25

EPS Next 2Y-14.54%

EPS Next 3Y-10%

Compared to an average S&P500 **Dividend Yield** of **2.37**, **CF** has a dividend comparable with the average S&P500 company.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.59% |

The dividend of **CF** has a limited annual growth rate of **5.68%**.

Dividend Growth(5Y)5.68%

Div Incr Years2

Div Non Decr Years18

The dividend of **CF** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP28.39%

EPS Next 2Y-14.54%

EPS Next 3Y-10%

**CF INDUSTRIES HOLDINGS INC**

NYSE:CF (6/12/2024, 2:52:07 PM)

**75.26**

**-1.55 (-2.02%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap13.76B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.59% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.89 | ||

Fwd PE | 12.37 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.25

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.36% | ||

ROE | 21.31% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 29.05% | ||

PM (TTM) | 19.03% | ||

GM | 34.34% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.44

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.55 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 3.94 | ||

Quick Ratio | 3.55 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-59.53%

EPS 3Y76.69%

EPS 5Y

EPS Q2Q%

EPS Next Y-33.16%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-41.06%

Revenue growth 3Y17.15%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y